nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Zandu Realty Limited (NSE India Code : ZANDUREALT) BUY

Company Name :

Enter Company Name or NSE Code

ZANDUREALT Technical Levels

Resistance 2		1608.83
Resistance 1		1579.67
PIVOT		1559.83
Support 1		1530.67
Support 2		1481.67

ZANDUREALT Fundamentals

Earning Growth		%
Profit Margin
PE
EPS
Quarter

ZANDUREALT Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

ZANDUREALT Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

ZANDUREALT Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

ZANDUREALT Share Price on 5-10-2012

Open		1575.05
High		1590
Low		1530
Close		1539
Volume		4461
Change		-32.15 (-2.05%)

Series		EQ
Date of Listing		03-Feb-99
Paid Up Value		100
Face Value		100
Market Capital		0 Crores
52 Week High/Low		1910 / 1225

Sponsored Advertisement

Zandu Realty Limited Company Profile

Zandu Pharmaceutical Works was incorporated in Mumbai in 1919. The company is engaged in manufacturing drugs and pharmaceuticals preparations. Zandu`s product offering is in the range of ayurvedic and allopathic formulations. The company manufactures a wide range of ayurvedic products, specialising in rheumatology, gynaecology and central nervous system, among others. The company has more than 300 products in the form of ghritas, medical oils, churna, quath, tablets and pills. Some of the company`s brands include Zandu Balm, Zandu Pancharishta, Trisun and Zandu Kesri Jivan. Financials The company announced fall of 81.80% in standalone net profit on y-o-y basis to Rs 1.69 million, while total income fell 33.88% y-o-y basis to Rs 3.66 million for the quarter ended December 2010.

ZANDUREALT Intraday Realtime Chart

ZANDUREALT Corporate Announcements

DATE	PURPOSE
18-Jul-12	Outcome of Postal Ballot
12-Jun-12	Notice of Postal Ballot
31-May-12	Outcome of Board Meeting
30-May-12	Financial Result Updates
17-Apr-12	Updates

ZANDUREALT Corporate Actions

DATE	PURPOSE
14-Sep-11	Annual General Meeting
14-Sep-11	Annual General Meeting

ZANDUREALT Board Meetings

MEETING DATE	PURPOSE
14-Aug-12	Un-audited Financial Results
10-Feb-12	Un-audited Financial Results
14-Nov-11	Un-audited Financial Results
12-Aug-11	Un-audited Financial Results
30-May-11	Audited Financial Results

ZANDUREALT Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

How is the Retail Investor defined as?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer